Literature DB >> 2454265

Production of T-T hybrids from T cell clones. Direct comparison between cloned T cells and T hybridoma cells derived from them.

S Ozaki1, S K Durum, K Muegge, J York-Jolley, J A Berzofsky.   

Abstract

It has been assumed, without direct evidence, that T cell hybridomas and non-transformed T cell clones are both good models of normal Ag-specific T cells. To compare directly the difference in activation of cloned normal T cells and T hybridoma cells with the same TCR, cloned T hybridoma cells were obtained by fusing pre-established, myoglobin-specific, Iad-restricted T cell clones (14.5 and 9.27) with BW5147 cells. T cell clones were pre-activated with IL-2 as well as specific Ag before fusion. Cloned T hybridoma A3.4C6 was derived from Lys 140-specific and I-Ed-restricted clone 14.5. The other cloned T hybridoma, C7R14, was a fusion product of Glu 109-specific and I-Ad-restricted clone 9.27. Both T hybridomas showed the same Ag specificity and Ia restriction as the parental cloned T cells. However, C7R14 showed higher apparent affinity and broader cross-reactivity than 9.27. Clone 14.5, but not hybridoma A3.4C6, appeared to stimulate splenic cells to secrete cytokines inhibiting HT-2A cell proliferation. The most striking difference between the clones and hybridomas was that both clones, but neither of the matched hybridomas, were induced to synthesize IL-1 on stimulation with Ag. Finally, both cloned T cells and T hybridomas killed Ag-pulsed Iad-bearing B lymphoma target cells. This evidence suggests that killing function can be inherited from clones to hybridomas. However, the clones were much more efficient at killing than the hybridomas, and the hybridomas were more efficient at IL-2 production than the clones. Thus, matched pairs of clones and hybridomas differ in their capacity to mediate the two functions or may tend to be selected differently during cloning. Thus, although our results generally support the validity of T cell hybridomas as faithful models of the corresponding T cell clones, a number of subtle and not-so-subtle differences indicate that caution must be used in such an extrapolation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454265

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Self peptide requirement for class II major histocompatibility complex allorecognition.

Authors:  S Demotz; A Sette; K Sakaguchi; R Buchner; E Appella; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  Leptin inhibits stress-induced apoptosis of T lymphocytes.

Authors:  Y Fujita; M Murakami; Y Ogawa; H Masuzaki; M Tanaka; S Ozaki; K Nakao; T Mimori
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  Class II-restricted bifunctional T-cell hybridomas reactive to self- and foreign myelin basic protein.

Authors:  D C Rayner; L D Petrycky
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

4.  In vitro regulation of thyroglobulin (Tg) autoantibody production by Tg-specific T-cell lines and hybridomas.

Authors:  B R Champion; P Hutchings; D C Rayner; K Page; J Tite; A Cooke; I M Roitt
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

5.  Major histocompatibility complex class II-restricted cytotoxicity by self-myelin basic protein-reactive T-cell hybridomas: evidence for a tumour necrosis factor-independent nucleolytic mechanism.

Authors:  D C Rayner; L D Petrycky-Cox; M Diocee; E Rector
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

6.  Calcium response of helper T lymphocytes to antigen-presenting cells in a single-cell assay.

Authors:  N G Agrawal; J J Linderman
Journal:  Biophys J       Date:  1995-09       Impact factor: 4.033

7.  DM determines the cryptic and immunodominant fate of T cell epitopes.

Authors:  N K Nanda; A J Sant
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

8.  CD4 rat x rat and mouse x rat T cell hybridomas produced by fusion of established T cell lines and clones to W/Fu (C58NT)D.

Authors:  A M Boots; M J van Lierop; M H Wauben; P J van Kooten; E J Hensen; W van Eden
Journal:  J Immunol Methods       Date:  1991-11-05       Impact factor: 2.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.